Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
1.87 EUR | -2.50% | -5.56% | -47.40% |
Apr. 30 | AB Science S.A. Announces Slight Delay in Publication of Annual Financial Report 2023 | CI |
Apr. 04 | AB Science's Reconsideration Request for ALS Treatment Granted Eligibility in Canada | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-47.40% | 105M | |
+4.13% | 69.17B | |
+12.55% | 9.06B | |
-12.75% | 4.96B | |
+42.38% | 4.47B | |
+5.23% | 3.9B | |
+21.27% | 2.41B | |
-19.05% | 2.41B | |
-28.72% | 2.23B | |
+11.13% | 2.02B |
- Stock Market
- Equities
- AB Stock
- News AB Science
- AB Science Wins European Patent for Prostate Cancer Drug